RecruitingNCT06248580

Find HDV and Determine Its Status in Turkey

Find HDV and Determine Its Status in Turkey "SITU(HD)VATION"

Sponsor

Yaşar Bayındır, MD

Enrollment

20,000 participants

Start Date

Mar 11, 2024

Study Type

OBSERVATIONAL

Conditions

Hepatocellular Carcinoma Cirrhosis, Liver Fibrosis, Liver Chronic Hepatitis D Infection Transmission Vertical

Summary

The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C virus (HCV), and Human Immunodeficiency virus (HIV) infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study aims to find out how many people in Turkey who test positive for hepatitis B also have hepatitis D virus (HDV) infection, and what stage their HDV disease is at. HDV is a less well-known virus that can only infect people who already have hepatitis B, and it can make liver disease much worse. **You may be eligible if...** - You are 18 or older - You have tested positive for hepatitis B surface antigen (HBsAg) for at least 6 months - You are a citizen of the Republic of Turkey **You may NOT be eligible if...** - There are no exclusion criteria — all eligible adults with chronic hepatitis B in Turkey can participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTAnti Delta

Anti Delta by ELISA

Locations(2)

Guven Hospital

Ankara, Turkey (Türkiye)

Dicle University, Faculty of Medicine

Diyarbakır, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06248580

Related Trials

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

NCT044727671 location

SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma

NCT072747741 location

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

NCT069022461 location

Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab

NCT067102231 location

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

NCT065031461 location